1-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Diabetes & Endoc...
Top 10s
Diabetes & Endocrinology
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Adrenal Cortex
Bone & Mineral Metabolism
Diabetes & Obesity
Multiple Endocrine Disorders & Neoplasias
Neuro-Endocrinology & Pituitary
Reproductive Endocrinology
Thyroid
Related Sections
Female Subfertility & Gynecological Endocrinology
MOST VIEWED TOP 10 (from specialty journals) | Diabetes & Endocrinology | calculated on 1 December 2008
The "Most Viewed Top 10 (from specialty journals)" Top 10 lists are generated every day and comprise only articles published in specialty journals. The articles are ordered by the number of times an article's evaluation(s) has/have been viewed over the past 30 days. The general journals that are excluded from this list are;
Ama Arch Intern Med, Ann Intern Med, BMJ, Cell, CMAJ, J Clin Invest, JAMA, Lancet, N Engl J Med, Nat Med, Nature, Science.
browse faculty
| show Most Viewed (specialty journals) Papers in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Must Read
F1000 Factor
6.0
Confirmation
Critical role of the hypothalamic-pituitary-thyroid axis in bone.
Bassett JH, Williams GR
Bone
2008 Sep
43
(3):418-26 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Gordon Klein
Evaluated 3 Nov 2008
2
Must Read
F1000 Factor
6.0
Changes
Clinical Practice
New Finding
The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss.
Fleischer J, Stein EM, …, McMahon DJ, Silverberg SJ
J Clin Endocrinol Metab
2008 Oct
93
(10):3735-40 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Peter Ebeling with Claudia Gagnon
Evaluated 5 Nov 2008
3
Exceptional
F1000 Factor
9.0
New Finding
The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development.
Chang W, Tu C, …, Bikle D, Shoback D
Sci Signal
2008
1
(35):ra1 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Peter Fuller
Evaluated 9 Oct 2008
4
Recommended
F1000 Factor
3.0
Controversial
In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines.
Zito G, Richiusa P, …, Galluzzo A, Giordano C
PLoS ONE
2008
3
(10):e3544 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Gilbert Cote
Evaluated 11 Nov 2008
5
Recommended
F1000 Factor
3.0
Confirmation
Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency.
Bensing S, Brandt L, …, Blomqvist P, Kämpe O
Clin Endocrinol (Oxf)
2008 Aug 22
69
[
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| John Newell-Price with Miguel Debono
Evaluated 7 Nov 2008
6
Must Read
F1000 Factor
6.0
Confirmation
The effect of alendronate on progression of spinal osteophytes and disc-space narrowing.
Neogi T, Nevitt MC, …, Bauer D, Felson DT
Ann Rheum Dis
2008 Oct
67
(10):1427-30 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jon Tobias with Emma Clark
Evaluated 28 Oct 2008
7
Recommended
F1000 Factor
3.0
Controversial
Retinol and alpha-Tocopherol in Morbid Obesity and Nonalcoholic Fatty Liver Disease.
Botella-Carretero JI, Balsa JA, …, Díaz-Enriquez M, Escobar-Morreale HF
Obes Surg
2008 Oct 2 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Zecharia Madar
Evaluated 28 Oct 2008
8
Must Read
F1000 Factor
4.8
New Finding
Controversial
Refutation
Deoxyribonucleic Acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.
Schweppe RE, Klopper JP, …, Smallridge RC, Haugen BR
J Clin Endocrinol Metab
2008 Nov
93
(11):4331-41 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Barry Nelkin / Gilbert Cote
First evaluation 4 Sep 2008 | Latest evaluation 10 Nov 2008
9
Must Read
F1000 Factor
6.0
New Finding
Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM, Duran EH, …, Leader B, Stadtmauer L
Am J Obstet Gynecol
2008 Aug
199
(2):202.e1-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Sarah Berga with Pavna Brahma
Evaluated 30 Oct 2008
10
Recommended
F1000 Factor
3.0
New Finding
Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
Miller M, Chen S, Woodliff J, Kansra S
Endocrinology
2008 Aug
149
(8):4158-67 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Gunter Stalla with Ulrich Renner
Evaluated 26 Sep 2008
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info
Confirmation
New Finding
Controversial
Refutation